FI974172A0 - B-adrenergisiä agonisteja - Google Patents
B-adrenergisiä agonistejaInfo
- Publication number
- FI974172A0 FI974172A0 FI974172A FI974172A FI974172A0 FI 974172 A0 FI974172 A0 FI 974172A0 FI 974172 A FI974172 A FI 974172A FI 974172 A FI974172 A FI 974172A FI 974172 A0 FI974172 A0 FI 974172A0
- Authority
- FI
- Finland
- Prior art keywords
- adrenergic agonists
- adrenergic
- agonists
- Prior art date
Links
- 239000000048 adrenergic agonist Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Emergency Medicine (AREA)
- Psychiatry (AREA)
- Neurosurgery (AREA)
- Reproductive Health (AREA)
- Child & Adolescent Psychology (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IB1995/000344 WO1996035671A1 (en) | 1995-05-10 | 1995-05-10 | β-ADRENERGIC AGONISTS |
| CA002220399A CA2220399A1 (en) | 1995-05-10 | 1995-05-10 | .beta.-adrenergic agonists |
| HU9601240A HUP9601240A1 (en) | 1995-05-10 | 1996-05-09 | Pyridin and pyrimidin derivatives, suitable as beta-adrenerg agonists, pharmaceutical compositions containing the same and their intermediates |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI974172A FI974172A (fi) | 1997-11-07 |
| FI974172A0 true FI974172A0 (fi) | 1997-11-07 |
Family
ID=89993954
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI974172A FI974172A0 (fi) | 1995-05-10 | 1997-11-07 | B-adrenergisiä agonisteja |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US5977124A (xx) |
| EP (1) | EP0824519A1 (xx) |
| JP (1) | JPH11504649A (xx) |
| KR (1) | KR100190259B1 (xx) |
| AU (1) | AU706235B2 (xx) |
| BR (1) | BR9602209A (xx) |
| CA (1) | CA2220399A1 (xx) |
| CO (1) | CO4440567A1 (xx) |
| CZ (1) | CZ132196A3 (xx) |
| FI (1) | FI974172A0 (xx) |
| HU (1) | HUP9601240A1 (xx) |
| IL (1) | IL118115A0 (xx) |
| MX (1) | MX9708621A (xx) |
| NO (1) | NO307049B1 (xx) |
| NZ (1) | NZ286548A (xx) |
| PL (1) | PL314120A1 (xx) |
| SG (1) | SG43365A1 (xx) |
| TR (1) | TR199600358A2 (xx) |
| WO (1) | WO1996035671A1 (xx) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5981562A (en) * | 1996-01-30 | 1999-11-09 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| US6008361A (en) * | 1996-04-09 | 1999-12-28 | Pfizer Inc. | Substituted pyridines |
| US6031105A (en) * | 1996-04-09 | 2000-02-29 | Pfizer Inc | Substituted pyridines |
| JP3510635B2 (ja) | 1996-11-14 | 2004-03-29 | ファイザー・インク | 置換ピリジン類の製法 |
| US6001856A (en) * | 1997-06-13 | 1999-12-14 | Pfizer Inc. | β-adrenergic agonists to reduce a wasting condition |
| EP0920864A1 (en) * | 1997-12-03 | 1999-06-09 | Pfizer Products Inc. | Combination therapy including a specific beta-3 agonist and an anorectic agent |
| US6657063B1 (en) * | 1998-04-30 | 2003-12-02 | Pfizer Inc. | Combinations of β3 agonists and growth hormone secretagogues |
| US6090942A (en) * | 1998-10-15 | 2000-07-18 | Pfizer Inc. | Process and intermediates for a β3 -adrenergic receptor agonist |
| DE60015036T2 (de) | 1999-07-23 | 2006-03-02 | Pfizer Products Inc., Groton | Zwischenprodukte und ein Verfahren zur Herstellung von beta3-Adrenergischer Rezeptor-Agoniste |
| EP1218336A2 (en) * | 1999-09-20 | 2002-07-03 | Takeda Chemical Industries, Ltd. | Melanin concentrating hormone antagonist |
| US6451587B1 (en) | 1999-09-29 | 2002-09-17 | Pfizer Inc. | Microbial asymmetric reduction of 2-chloro-1-[-6-(2,5-dimethyl-pyrrol-1-yl)-pyridin-3-yl]-ethanone |
| AU2001252574B2 (en) * | 2000-04-28 | 2005-03-17 | Asahi Kasei Pharma Corporation | Novel bicyclic compounds |
| AU2001292161A1 (en) | 2000-10-20 | 2002-04-29 | Pfizer Products Inc. | Alpha-aryl ethanolamines and their use as beta-3 adrenergic receptor agonists |
| EP1236723A1 (en) * | 2001-03-01 | 2002-09-04 | Pfizer Products Inc. | Sulfamide derivatives useful as beta3 agonists and pharmaceutical uses thereof |
| US6864268B2 (en) | 2002-02-27 | 2005-03-08 | Pfizer Inc. | β3 adrenergic receptor agonists |
| DOP2003000587A (es) * | 2002-02-27 | 2003-08-30 | Pfizer Prod Inc | AGONISTAS DEL RECEPTOR ß3-ADRENERGICO |
| WO2003072573A1 (en) | 2002-02-27 | 2003-09-04 | Pfizer Products Inc. | Crystal forms of (r)-2-(2-(4-oxazol-4-yl-phenoxy)-ethylamino)-1-pyridin-3-yl-ethanol |
| MXPA04008298A (es) | 2002-02-27 | 2004-11-26 | Pfizer Prod Inc | Procesos e intermedios utiles en la preparacion de agonistas de receptor beta-3 adrenergico. |
| US20050075323A1 (en) * | 2003-03-05 | 2005-04-07 | Pfizer Inc | Beta3 adrenergic receptor agonists and uses thereof |
| EP1477167A1 (en) * | 2003-05-15 | 2004-11-17 | Pfizer Limited | [(2-hydroxy-2-(4-hydroxy-3-hydroxymethylphenyl)-ethylamino)-propyl] phenyl derivatives as beta2 agonists |
| GB0312832D0 (en) * | 2003-06-04 | 2003-07-09 | Pfizer Ltd | 2-amino-pyridine derivatives useful for the treatment of diseases |
| US7375100B2 (en) * | 2003-06-04 | 2008-05-20 | Pfizer Inc | 2-amino-pyridine derivatives useful for the treatment of diseases |
| KR101071748B1 (ko) * | 2003-12-23 | 2011-10-11 | 아스텔라스세이야쿠 가부시키가이샤 | 아미노알콜 유도체 |
| WO2006051373A1 (en) * | 2004-11-12 | 2006-05-18 | Pfizer Limited | Compounds for the treatment of diseases |
| EP2356997A1 (en) | 2005-06-06 | 2011-08-17 | Georgetown University | Compositions and methods for lipo modeling |
| BRPI0903206E2 (pt) | 2009-09-01 | 2015-07-28 | Da Silva Antonio Carlos Nunes Ett | Unidade processadora e método de processamento de fraldas e absorventes |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4358455A (en) * | 1980-12-23 | 1982-11-09 | Merck & Co., Inc. | Aralkylamindethanol heterocyclic compounds |
| DE3278014D1 (en) * | 1982-10-01 | 1988-02-25 | Merck & Co Inc | Aralkylaminoethanol heterocyclic compounds |
| CA1287061C (en) * | 1986-06-27 | 1991-07-30 | Roche Holding Ltd. | Pyridine ethanolamine derivatives |
| GB8703007D0 (en) * | 1987-02-10 | 1987-03-18 | Glaxo Group Ltd | Chemical compounds |
| NZ226991A (en) * | 1987-11-27 | 1992-03-26 | Merck & Co Inc | Alpha-heterocyclically-substituted ethanolamines and use as animal growth promotors |
| US5019578A (en) * | 1987-11-27 | 1991-05-28 | Merck & Co., Inc. | β-adrenergic agonists |
| US5216170A (en) * | 1989-01-26 | 1993-06-01 | Bayer Aktiengesellschaft | (2-aminopropyl) pyridines useful as intermediates |
| GB9209076D0 (en) * | 1992-04-27 | 1992-06-10 | Ici Plc | Chemical compounds |
| US5599966A (en) * | 1992-10-16 | 1997-02-04 | Byk Nederland Bv | Substituted ethanolamine esters |
| JPH08505846A (ja) * | 1992-12-29 | 1996-06-25 | スミスクライン・ビーチャム・コーポレイション | 血小板凝集阻害用化合物 |
| US5451677A (en) * | 1993-02-09 | 1995-09-19 | Merck & Co., Inc. | Substituted phenyl sulfonamides as selective β 3 agonists for the treatment of diabetes and obesity |
| JPH08509491A (ja) * | 1993-04-26 | 1996-10-08 | 藤沢薬品工業株式会社 | 胃腸疾患の治療に有用なエタノールアミン誘導体 |
| KR960703120A (ko) * | 1993-06-14 | 1996-06-19 | 알렌 제이. 스피겔 | 당뇨 및 비만 치료제로서의 2차아민(secondary amines as antidiabetic and antiobesity agents) |
| JPH08165276A (ja) * | 1994-12-14 | 1996-06-25 | Dainippon Pharmaceut Co Ltd | ２−アルキルアミノ−１−フェニルエタノール誘導体 |
-
1995
- 1995-05-10 MX MX9708621A patent/MX9708621A/es not_active Application Discontinuation
- 1995-05-10 WO PCT/IB1995/000344 patent/WO1996035671A1/en not_active Application Discontinuation
- 1995-05-10 EP EP95915995A patent/EP0824519A1/en not_active Ceased
- 1995-05-10 CA CA002220399A patent/CA2220399A1/en not_active Abandoned
- 1995-05-10 US US08/945,551 patent/US5977124A/en not_active Expired - Fee Related
- 1995-05-10 JP JP8533903A patent/JPH11504649A/ja active Pending
-
1996
- 1996-05-02 IL IL11811596A patent/IL118115A0/xx unknown
- 1996-05-03 TR TR96/00358A patent/TR199600358A2/xx unknown
- 1996-05-07 SG SG1996009751A patent/SG43365A1/en unknown
- 1996-05-07 CZ CZ961321A patent/CZ132196A3/cs unknown
- 1996-05-08 PL PL96314120A patent/PL314120A1/xx unknown
- 1996-05-08 CO CO96022964A patent/CO4440567A1/es unknown
- 1996-05-09 NZ NZ286548A patent/NZ286548A/en unknown
- 1996-05-09 AU AU52185/96A patent/AU706235B2/en not_active Ceased
- 1996-05-09 HU HU9601240A patent/HUP9601240A1/hu unknown
- 1996-05-09 NO NO961887A patent/NO307049B1/no not_active IP Right Cessation
- 1996-05-09 KR KR1019960015262A patent/KR100190259B1/ko not_active IP Right Cessation
- 1996-05-10 BR BR9602209A patent/BR9602209A/pt active Search and Examination
-
1997
- 1997-11-07 FI FI974172A patent/FI974172A0/fi unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL118115A0 (en) | 1996-09-12 |
| EP0824519A1 (en) | 1998-02-25 |
| NO961887L (no) | 1996-11-11 |
| CZ132196A3 (en) | 1997-03-12 |
| AU706235B2 (en) | 1999-06-10 |
| AU5218596A (en) | 1996-11-21 |
| KR960041168A (ko) | 1996-12-19 |
| NZ286548A (en) | 1998-03-25 |
| NO307049B1 (no) | 2000-01-31 |
| MX9708621A (es) | 1998-02-28 |
| JPH11504649A (ja) | 1999-04-27 |
| HUP9601240A1 (en) | 1997-09-29 |
| PL314120A1 (en) | 1996-11-12 |
| FI974172A (fi) | 1997-11-07 |
| BR9602209A (pt) | 1998-04-07 |
| SG43365A1 (en) | 1997-10-17 |
| HU9601240D0 (en) | 1996-07-29 |
| KR100190259B1 (ko) | 1999-06-01 |
| NO961887D0 (no) | 1996-05-09 |
| CO4440567A1 (es) | 1997-05-07 |
| WO1996035671A1 (en) | 1996-11-14 |
| US5977124A (en) | 1999-11-02 |
| TR199600358A2 (tr) | 1996-11-21 |
| CA2220399A1 (en) | 1996-11-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI974172A (fi) | B-adrenergisiä agonisteja | |
| DE69627551D1 (de) | Lüftströmungssteuervorrichtung | |
| DE69612617D1 (de) | Chloridunterstützte hydrometallurgische metallextraktion | |
| DE69615614T2 (de) | N-Heterocyclyl-biphenyl-sulfonamide | |
| DE69623501D1 (de) | Tiernährungssauger | |
| DE69524382T2 (de) | Spiralverdrängermaschine | |
| DE69634974D1 (de) | Spreizspektrumnachrichtenübertragungssystem | |
| FI974170A (fi) | B-adrenergisiä agonisteja | |
| IS4679A (is) | Bensóþíasólonafleiður | |
| DE69605312D1 (de) | Rettungsflösse | |
| FI973287A (fi) | Klavulaanihapposuoloja | |
| ITPG950027V0 (it) | Matic-straw | |
| NO954921L (no) | Stigerörsystem | |
| DE69624414T2 (de) | Hochgeschwindigkeitskodierer | |
| KR970009914U (ko) | 외등이 설치된 정자 | |
| KR960030200U (ko) | 필통 | |
| KR970005654U (ko) | 환경캔 | |
| FI951528A0 (fi) | Tofttrappa; anordning foer stigning fraon vatten i baot | |
| FR2732104B1 (fr) | Repose-fleches | |
| NO955062D0 (no) | Rörledning | |
| FI1842U1 (fi) | Staellning foer braensle | |
| FI2030U1 (fi) | Faestbygel | |
| FI2059U1 (fi) | Blomstermylle skydd | |
| FI2150U1 (fi) | Serieblankett | |
| FI1990U1 (fi) | Kopplingsdosa |